Could a simple nasal device replace ventilators for COPD emergencies?

NCT ID NCT06114667

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a nasal high-flow device to standard non-invasive ventilation (NIV) for treating people who come to the emergency room with a severe COPD flare-up and high carbon dioxide levels. Participants are randomly assigned to receive one of the two breathing supports for two-hour sessions. Researchers measure whether the nasal device is as good as NIV at bringing blood gas levels back to normal.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nasal high flow device
What this could lead to
If successful, this could offer a simpler, more comfortable breathing support option for people with COPD flare-ups in the emergency room.
What could go wrong
This is a single study with 174 participants, and it only looks at early treatment in the emergency department. The nasal high flow may not work as well as standard care for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier Universitaire de Poitiers

    NOT_YET_RECRUITING

    Poitiers, France

  • Centre hospitalier universitaire de Nimes

    NOT_YET_RECRUITING

    Nîmes, France

  • Montpellier University Hospital

    RECRUITING

    Montpellier, Montepllier, 34000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.